Evidence map›Paper›PMID 31597658›Full record

ArticleDevelopment (Cambridge, England)2019

Regulation of nuclear-cytoplasmic partitioning by the

Orkan Ilbay, Victor Ambros

Open access · bronzeAbstract read
In one paragraph

Article in Development (Cambridge, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. microPublication biology · 2025
    Article
  7. Article
  8. Modeling neurodevelopmental disorder-associated humanProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Orkan IlbayProgram in Molecular Medicine, University of Massachusetts Medical School, 373 Plantation Street, Worcester, MA 01605, USA.ORCID 0000-0002-7963-5054
Victor AmbrosProgram in Molecular Medicine, University of Massachusetts Medical School, 373 Plantation Street, Worcester, MA 01605, USA victor.ambros@umassmed.edu.ORCID 0000-0002-5562-5345
University of Massachusetts Chan Medical School · US

Funding

GENETIC CONTROL OF NEMATODE DEVELOPMENTR01GM034028 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI AMBROS, VICTOR · 1985 to 2018
$7.0M
Genetic control of developmental timingR35GM131741 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Victor Ambros · 2019 to 2026
$5.9M
Developmental Regulation of MicroRNA ExpressionR01GM088365 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI AMBROS, VICTOR · 2009 to 2010
$771k
NIGMS NIH HHS R01 GM034028NIGMS NIH HHS R01 GM088365NIGMS NIH HHS R35 GM131741
6 · The paper itself

Abstract

MicroRNAs target complementary mRNAs for degradation or translational repression, reducing or preventing protein synthesis. In

Indexed as

Gene Expression Regulation, Developmental3' Untranslated RegionsAdaptor Proteins, Signal TransducingAllelesAnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsCell DifferentiationCell LineageCell NucleusCRISPR-Cas SystemsCytoplasmDisease ProgressionDNA-Binding ProteinsDown-RegulationGene Deletion3' Untranslated RegionsAdaptor Proteins, Signal TransducingCaenorhabditis elegans ProteinsDNA-Binding Proteinshbl-1 protein, C elegansLIN-28 protein, C elegansLin-46 protein, C elegansMicroRNAsRepressor ProteinsRNA-Binding ProteinsTranscription FactorsCell-fate progressionDevelopmental robustnessHeterochronicmicroRNANuclear-cytoplasmic partitioningTranscription factor

Identifiers

PMID31597658
PMCPMC6857590
OpenAlexW2979619908

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.